Robert Martin Email

VP Nonclinical Development and Project Management . CymaBay Therapeutics

Current Roles

Employees:
122
Revenue:
$6.8M
About
CymaBay Therapeutics, Inc. (CBAY) is a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet medical need. Seladelpar is a potent, selective, orally active PPAR agonist, currently in development for the treatment of patients with primary biliary cholangitis (PBC), an autoimmune liver disease, and with non-alcoholic steatohepatitis (NASH). For additional information about CymaBay visit www.cymabay.com.
CymaBay Therapeutics Address
7575 Gateway Blvd
Newark, CA
United States
CymaBay Therapeutics Email

Past Companies

MetabolexVice President of Project and Portfolio Management
CymaBay TherapeuticsVice President of Nonclinical Development and Project Management
Roche Palo AltoPortfolio Strategy Manager

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.